首页> 外文OA文献 >Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma

【2h】

Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma

机译：紫杉醇，Ifosfamide和顺铂作为局部晚期宫颈癌新辅助化疗的疗效和耐受性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Giuseppa Scandurra; Giuseppe Scibilia; Giuseppe Luigi Banna; Gabriella DAgate; Helga Lipari; Stefania Gieri; Paolo Scollo;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma [J] . Scandurra Giuseppa, Scibilia Giuseppe, Banna Giuseppe Luigi, Journal of Gynecologic Oncology . 2015,第2期

机译：紫杉醇，异环磷酰胺和顺铂作为局部晚期宫颈癌新辅助化疗的疗效和耐受性
2. Randomized Trial of Neoadjuvant Chemotherapy Comparing Paclitaxel, Ifosfamide, and Cisplatin With Ifosfamide and Cisplatin Followed by Radical Surgery in Patients With Locally Advanced Squamous Cell Cervical Carcinoma: The SNAP01 (Studio Neo-Adjuvant [J] . Buda A, Fossati R, Colombo N, Journal of Clinical Oncology . 2005,第18期

机译：局部晚期鳞状细胞宫颈癌患者接受紫杉醇，异环磷酰胺和顺铂与异环磷酰胺和顺铂进行根治性手术的新辅助化疗的随机对照试验：SNAP01（Studio新辅助化疗）
3. A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study [J] . A. A. Lissoni1 N. Colombo2 A. Pellegrino1 G. Parma2 P. Zola3 D. Katsaros4 S. Chiari1 A. Buda1 F. Landoni2 M. Peiretti2 T. DellAnna1 R. Fruscio1 M. Signorelli1 R. Grassi5 I. Floriani6 R. Fossati6* V. Torri6 and E. Rulli6 Annals of Oncology . 2009,第4期

机译：一项新的辅助化疗的II期随机试验，比较了紫杉醇，异环磷酰胺和顺铂（TIP）与紫杉醇和顺铂（TP）的三药联合治疗对局部晚期鳞状上皮宫颈癌患者进行的根治性手术： -02意大利合作研究
4. CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma [C] . Zhien Feng, Lizhen Wang, Bingshun Wang, Academic Committee Conference of Shanghai key lab of stomatology . 2011

机译：CCND1作为局部晚期头颈部鳞状细胞癌患者新辅助化疗的预测生物标志物
5. Intenzivnej?e neoadjuvantno zdravljenje lokalno napredovalnega raka danke =Intensified neoadjuvant treatment of locally advanced rectal cancer [D] . Golo, Danijela. 2018

机译：强烈的Neoadjuvant治疗局部晚期癌症射线=加强Neoadjuvant治疗局部晚期直肠癌
6. Efficacy and tolerability of paclitaxel ifosfamide and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma [O] . Giuseppa Scandurra, Giuseppe Scibilia, Giuseppe Luigi Banna, 2015

机译：紫杉醇异环磷酰胺和顺铂在局部晚期宫颈癌中作为新辅助化疗的疗效和耐受性
7. Analysis of short-term efficacy as defined by RECIST and pathological response of neoadjuvant chemotherapy comprised paclitaxel and cisplatin followed by radical surgery in patients with locally advanced cervical cancer [O] . Yue He, Qun Zhao, Yu-Ning Geng, 2018

机译：Neoadjuvant化疗的再思科和病理反应定义的短期疗效分析包括紫杉醇和顺铂，随后临床宫颈癌患者的自由基手术

Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma

著录项

引文网络

相似文献

相关主题

期刊订阅